1 National Institutes of Health. 2007. National Institute of Neurological Disorders and Stroke Fact Sheet. Accessed June 28, 2007.
2 Creutzfeldt-Jakob Disease Foundation. 2007. Creutzfeldt-Jakob Disease and other Prion Diseases. Accessed June 28, 2007.
3 CDC. 2007. Centers for Disease Control and Prevention vCJD Homepage. Accessed June 28, 2007.
4 Centers for Disease Control and Prevention, vCJD Fact Sheet (through November 2006).
5 Will, R.G., J.W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P.G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:921-25.
6 Collinge J., K.C. Sidle, J. Meads, J. Ironside, and A.F. Hill. 1996. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature. 383(6602):685-90.
7 Brown, P., R.G. Will, R. Bradley, D. Asher, and L. Detwiler. 2001. Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease: Background, Evolution and Current Concerns. Emerg. Infect. Dis. 7:1
8 The European and Allied Countries Collaborative Study Group of CJD (EUROCJD) plus the Extended Collaborative Study Group of CJD (NEUROCJD) (through December 2007). Accessed Jan. 26, 2008.
9 Health Protection Agency. 2007. 4th case of variant CJD infection associated with blood transfusion. Accessed Sept. 5, 2007.
10 Schonberger, L. (personal communication, Nov. 12, 2007)
11 National Prion Disease Pathology Surveillance Center. 2007. Accessed June 28, 2007.
12 Zeidler, M., R.J. Seller, D.A. Collie, R. Knight, G. Stewart, M.A. Macleod, J.W. Ironside, S. Cousens, A.C. Colchester, D.M. Hadley, and R.G. Will. 2000. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet. 355(9213):1412-8.
13 Boesenberg-Grosse, C., W.J. Schulz-Schaeffer, M. Bodemer, B. Ciesielczyk, B. Meissner, A. Krasnianski, M. Bartl, U. Heinemann, D. Varges, S. Eigenbrod, H.A. Kretzschmar, A. Green, and I. Zerr. 2006. Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? BMC Neurol. 6:35
14 Hill, A.F., R.J. Butterworth, S. Joiner, G. Jackson, M.N. Rossor, D.J. Thomas, A. Frosh, N. Tolley, J.E. Bell, M. Spencer, A. King, S. Al-Sarraj, J.W. Ironside, P.L. Lantos, and J. Collinge. 1999. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 353(9148):183-9.
15 FDA. 2002. Guidance for Industry: Revised Precautionary Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and New Variant Creutzfeldt-Jakob Disease (nvCJD) by Blood and Blood Products.
Back to Top